ArticleNeurospine2023

The Combined Effects of RhBMP-2 and Systemic RANKL Inhibitor in Patients With Bone Density Loss Undergoing Posterior Lumbar Interbody Fusion: A Retrospective Observational Analysis With Propensity Score Matching.

Seungjun Ryu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.